hims & hers fda warning letter compounded semaglutide 2025 💊 $HIMS Big Picture… 1. received a addressed to @AndrewDudum on September 9, 2025. Andrew had to respond to the letter with specific steps they'd change from their Hims is in the crosshairs.

Cited violations included sameness claims equating compounded products with approved brands and trademarked marketing that obscured the actual compounding source and responsibilities

Results from TRIUMPH-1, 2, and 3 are expected throughout 2026

Its structure allows it to bind to albumin in the bloodstream, which slows down breakdown and clearance

The FDA initially approved semaglutide under the brand name Ozempic in 2017 for managing type 2 diabetes, though it is sometimes prescribed off-label for weight loss

How quickly does Semaglutide GLP-1 work

Step 3: Add daily steps target 7,000+ before adding more gym volume